West Pharmaceutical Services Inc
WST272.440USD
+3.780+1.41%
Handelsschluss 12/19, 16:00（ET）Kurse um 15 Minuten verzögert
19.59BMarktkapitalisierung
40.12KGV TTM
mehr Informationen über West Pharmaceutical Services Inc Unternehmen
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
West Pharmaceutical Services Inc Informationen
BörsenkürzelWST
Name des UnternehmensWest Pharmaceutical Services Inc
IPO-datumSep 01, 2059
CEOGreen (Eric Mark)
Anzahl der mitarbeiter10600
WertpapierartOrdinary Share
GeschäftsjahresendeSep 01
Addresse530 Herman O. West Drive
StadtEXTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl19341
Telefon16105942900
Websitehttps://www.westpharma.com/
BörsenkürzelWST
IPO-datumSep 01, 2059
CEOGreen (Eric Mark)
Führungskräfte von West Pharmaceutical Services Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Mr. Paolo Pucci
Mr. Paolo Pucci
Independent Director
Independent Director
10.46K
+11.41%
Mr. Robert F. (Rob) Friel
Mr. Robert F. (Rob) Friel
Lead Independent Director
Lead Independent Director
4.14K
+34.90%
Dr. Stephen H. Lockhart, M.D., Ph.D.
Dr. Stephen H. Lockhart, M.D., Ph.D.
Independent Director
Independent Director
2.16K
+98.08%
Ms. Janet Brutschea Haugen
Ms. Janet Brutschea Haugen
Independent Director
Independent Director
1.56K
+216.80%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Eric Mark Green
Mr. Eric Mark Green
Non-Independent Chairman of the Board, President, Chief Executive Officer
Non-Independent Chairman of the Board, President, Chief Executive Officer
171.12K
+1.58%
Mr. Douglas A. Michels
Mr. Douglas A. Michels
Independent Director
Independent Director
44.97K
+2.44%
Mr. Thomas W. (Tom) Hofmann
Mr. Thomas W. (Tom) Hofmann
Independent Director
Independent Director
42.94K
+2.56%
Mr. Mark A. Buthman
Mr. Mark A. Buthman
Independent Director
Independent Director
42.80K
+2.57%
Ms. Annette F. Favorite
Ms. Annette F. Favorite
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
21.84K
+4.40%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Independent Director
Independent Director
19.01K
+5.97%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
High Value Components
360.25M
47.00%
Standard Packaging
160.97M
21.00%
Contract-Manufactured Products
145.63M
19.00%
Delivery Devices
99.64M
13.00%
Nach RegionUSD
Name
Umsatz
Anteil
Europe Middle East and Africa
352.59M
46.00%
Americas
344.93M
45.00%
Asia Pacific
68.98M
9.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
High Value Components
360.25M
47.00%
Standard Packaging
160.97M
21.00%
Contract-Manufactured Products
145.63M
19.00%
Delivery Devices
99.64M
13.00%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
13.44%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.46%
Artisan Partners Limited Partnership
3.85%
Brown Advisory
3.47%
Andere
69.50%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
13.44%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.46%
Artisan Partners Limited Partnership
3.85%
Brown Advisory
3.47%
Andere
69.50%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
48.04%
Investment Advisor/Hedge Fund
32.14%
Hedge Fund
6.92%
Pension Fund
4.01%
Research Firm
2.24%
Bank and Trust
1.82%
Sovereign Wealth Fund
1.37%
Insurance Company
0.76%
Endowment Fund
0.62%
Andere
2.09%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
1640
70.77M
98.37%
-2.34M
2025Q2
1636
72.03M
100.16%
-1.82M
2025Q1
1662
71.25M
99.16%
-2.66M
2024Q4
1626
70.93M
98.10%
-2.28M
2024Q3
1603
70.42M
97.07%
-3.49M
2024Q2
1609
70.03M
96.14%
-3.89M
2024Q1
1617
70.47M
96.25%
-3.65M
2023Q4
1622
70.59M
95.41%
-3.14M
2023Q3
1619
70.63M
95.63%
-3.16M
2023Q2
1600
70.17M
94.52%
-5.10M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
9.28M
12.91%
+83.24K
+0.90%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.79M
5.27%
-358.56K
-8.65%
Jun 30, 2025
State Street Investment Management (US)
3.27M
4.55%
+68.33K
+2.13%
Jun 30, 2025
Artisan Partners Limited Partnership
2.27M
3.15%
+71.84K
+3.27%
Jun 30, 2025
Brown Advisory
3.02M
4.2%
-247.19K
-7.56%
Jun 30, 2025
Walter Scott & Partners Ltd.
2.20M
3.06%
-142.10K
-6.07%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.83M
2.55%
-20.69K
-1.12%
Jun 30, 2025
Van Eck Associates Corporation
1.49M
2.07%
+38.34K
+2.65%
Jun 30, 2025
APG Asset Management N.V.
1.66M
2.31%
+96.53K
+6.18%
Jun 30, 2025
Durable Capital Partners LP
1.04M
1.45%
-532.47K
-33.85%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Motley Fool Mid-Cap Growth ETF
3.52%
VanEck Morningstar Wide Moat ETF
2.83%
First Trust Indxx Medical Devices ETF
2.15%
VanEck Morningstar Wide Moat Value ETF
2.14%
Invesco S&P 500 Equal Weight Health Care ETF
1.8%
Nuveen ESG Mid-Cap Growth ETF
1.72%
American Century Mid Cap Growth Impact ETF
1.63%
Hilton Small-MidCap Opportunity ETF
1.51%
iShares Health Innovation Active ETF
1.5%
ProShares S&P 500 Dividend Aristocrats ETF
1.46%
Mehr Anzeigen
Motley Fool Mid-Cap Growth ETF
Anteil3.52%
VanEck Morningstar Wide Moat ETF
Anteil2.83%
First Trust Indxx Medical Devices ETF
Anteil2.15%
VanEck Morningstar Wide Moat Value ETF
Anteil2.14%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.8%
Nuveen ESG Mid-Cap Growth ETF
Anteil1.72%
American Century Mid Cap Growth Impact ETF
Anteil1.63%
Hilton Small-MidCap Opportunity ETF
Anteil1.51%
iShares Health Innovation Active ETF
Anteil1.5%
ProShares S&P 500 Dividend Aristocrats ETF
Anteil1.46%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
269.40M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jul 24, 2025
WST.NB Final Cash Dividend of gross USD 0.22 paid on Nov 19, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 19, 2025
Nov 12, 2025
Apr 24, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Aug 06, 2025 going ex on Jul 30, 2025
Jul 30, 2025
Aug 06, 2025
Jul 30, 2025
Feb 20, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on May 07, 2025 going ex on Apr 30, 2025
Apr 30, 2025
May 07, 2025
Apr 30, 2025
Jan 28, 2025
WST.NB Interim Cash Dividend of gross USD 0.21 paid on Feb 11, 2025 going ex on Feb 07, 2025
Feb 07, 2025
Feb 11, 2025
Feb 07, 2025
Oct 24, 2024
WST.NB Final Cash Dividend of gross USD 0.21 paid on Nov 20, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 20, 2024
Nov 13, 2024
Apr 25, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Aug 07, 2024 going ex on Jul 31, 2024
Jul 31, 2024
Aug 07, 2024
Jul 31, 2024
Feb 20, 2024
WST.NB Interim Cash Dividend of gross USD 0.2 paid on May 01, 2024 going ex on Apr 23, 2024
Apr 24, 2024
May 01, 2024
Apr 23, 2024
Dec 06, 2023
WST.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 07, 2024 going ex on Jan 30, 2024
Jan 31, 2024
Feb 07, 2024
Jan 30, 2024
Oct 26, 2023
WST.NB Final Cash Dividend of gross USD 0.2 paid on Nov 15, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 15, 2023
Nov 07, 2023
Apr 27, 2023
WST.NB Interim Cash Dividend of gross USD 0.19 paid on Aug 02, 2023 going ex on Jul 25, 2023
Jul 26, 2023
Aug 02, 2023
Jul 25, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von West Pharmaceutical Services Inc?
Die fünf größten Anteilseigner von West Pharmaceutical Services Inc sind:
The Vanguard Group, Inc. hält 9.28M Aktien, was 12.91% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 3.79M Aktien, was 5.27% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 3.27M Aktien, was 4.55% der Gesamtaktien entspricht.
Artisan Partners Limited Partnership hält 2.27M Aktien, was 3.15% der Gesamtaktien entspricht.
Brown Advisory hält 3.02M Aktien, was 4.20% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 9.28M Aktien, was 12.91% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 3.79M Aktien, was 5.27% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 3.27M Aktien, was 4.55% der Gesamtaktien entspricht.
Artisan Partners Limited Partnership hält 2.27M Aktien, was 3.15% der Gesamtaktien entspricht.
Brown Advisory hält 3.02M Aktien, was 4.20% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von West Pharmaceutical Services Inc?
Die drei wichtigsten Anteilseigner-Typen von West Pharmaceutical Services Inc sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wie viele Institutionen halten Anteile an West Pharmaceutical Services Inc (WST)?
Mit Stand vom 2025Q3 halten 1640 Institutionen Anteile an West Pharmaceutical Services Inc, mit einem Gesamtmarktwert von etwa 70.77M, was 98.37% der Gesamtanteile entspricht. Im Vergleich zum 2025Q2 ist der institutionelle Aktienbesitz um -1.79% gestiegen.
Was ist die größte Einnahmequelle von West Pharmaceutical Services Inc?
Am FY2025Q2 erzielte das Geschäft mit High Value Components für West Pharmaceutical Services Inc den höchsten Umsatz in Höhe von 360.25M, was 47.00% des Gesamtumsatzes entspricht.
